Related Experiment Videos
Nocturnal acid breakthrough - approach to management
Radu Tutuian1, Donald O Castell
1Division of Gastroenterology-Hepatology, Medical University of South Carolina, Charleston, South Carolina, USA.
Medgenmed : Medscape General Medicine
|March 19, 2005
Summary
Nocturnal acid breakthrough, a common issue for patients on proton-pump inhibitors (PPIs), can be effectively managed. Adding histamine-2 receptor antagonists (H2RAs) at bedtime helps control this condition and associated GERD symptoms.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Nocturnal acid breakthrough, defined as intragastric pH < 4 for 60+ minutes overnight during proton-pump inhibitor (PPI) therapy, affects over 70% of H. pylori-negative patients.
- This condition has significant clinical implications, particularly for individuals with complicated gastroesophageal reflux disease (GERD), Barrett's esophagus, and esophageal motility disorders.
Purpose of the Study:
- To evaluate the clinical importance of nocturnal acid breakthrough.
- To assess the efficacy of adding histamine-2 receptor antagonists (H2RAs) to PPI therapy for managing nocturnal acid breakthrough and GERD symptoms.
Main Methods:
- Observational analysis of patients experiencing nocturnal acid breakthrough while on PPI therapy.
- Clinical assessment of GERD symptoms and intragastric pH monitoring.
Main Results:
- Nocturnal acid breakthrough is prevalent in patients on PPIs, especially those negative for H. pylori.
- The addition of H2RAs at bedtime was found to be clinically effective in controlling nocturnal acid breakthrough.
Conclusions:
- Nocturnal acid breakthrough poses clinical challenges for patients with specific gastrointestinal conditions.
- Adding bedtime H2RAs to PPI therapy is an effective strategy for managing nocturnal acid breakthrough and alleviating GERD symptoms.